Literature DB >> 27637929

CeF3-ZnO scintillating nanocomposite for self-lighted photodynamic therapy of cancer.

Tiziano Rimoldi1, Davide Orsi1, Paola Lagonegro2, Benedetta Ghezzi3, Carlo Galli3, Francesca Rossi2, Giancarlo Salviati2, Luigi Cristofolini4.   

Abstract

We report on the synthesis and characterization of a composite nanostructure based on the coupling of cerium fluoride (CeF3) and zinc oxide (ZnO) for applications in self-lighted photodynamic therapy. Self-lighted photodynamic therapy is a novel approach for the treatment of deep cancers by low doses of X-rays. CeF3 is an efficient scintillator: when illuminated by X-rays it emits UV light by fluorescence at 325 nm. In this work, we simulate this effect by exciting directly CeF3 fluorescence by UV radiation. ZnO is photo-activated in cascade, to produce reactive oxygen species. This effect was recently demonstrated in a physical mixture of distinct nanoparticles of CeF3 and ZnO [Radiat. Meas. (2013) 59:139-143]. Oxide surface provides a platform for rational functionalization, e.g., by targeting molecules for specific tumors. Our composite nanostructure is stable in aqueous media with excellent optical coupling between the two components; we characterize its uptake and its good cell viability, with very low intrinsic cytotoxicity in dark.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27637929     DOI: 10.1007/s10856-016-5769-3

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  18 in total

1.  Liquid-Phase Synthesis of Colloids and Redispersible Powders of Strongly Luminescing LaPO(4):Ce,Tb Nanocrystals This work was supported by the Deutsche Forschungsgemeinschaft (DFG). We thank S. Bartholdi-Nawrath for help with the electron micrographs and J. Kolny for measuring the powder X-ray diffraction data.

Authors:  Karsten Riwotzki; Heike Meyssamy; Heimo Schnablegger; Andreas Kornowski; Markus Haase
Journal:  Angew Chem Int Ed Engl       Date:  2001-02-02       Impact factor: 15.336

2.  Nanocrystalline ZnO with ultraviolet luminescence.

Authors:  Y S Wang; P John Thomas; P O'Brien
Journal:  J Phys Chem B       Date:  2006-03-09       Impact factor: 2.991

Review 3.  Optical properties of ZnO nanostructures.

Authors:  Aleksandra B Djurisić; Yu Hang Leung
Journal:  Small       Date:  2006-08       Impact factor: 13.281

Review 4.  Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment.

Authors:  Wei Chen; Jun Zhang
Journal:  J Nanosci Nanotechnol       Date:  2006-04

5.  Nanoshell-enabled photothermal cancer therapy: impending clinical impact.

Authors:  Surbhi Lal; Susan E Clare; Naomi J Halas
Journal:  Acc Chem Res       Date:  2008-12       Impact factor: 22.384

Review 6.  Physical Principles of Nanoparticle Cellular Endocytosis.

Authors:  Sulin Zhang; Huajian Gao; Gang Bao
Journal:  ACS Nano       Date:  2015-08-21       Impact factor: 15.881

Review 7.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

Review 8.  The growing impact of click chemistry on drug discovery.

Authors:  Hartmuth C Kolb; K Barry Sharpless
Journal:  Drug Discov Today       Date:  2003-12-15       Impact factor: 7.851

Review 9.  Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer.

Authors:  Petras Juzenas; Wei Chen; Ya-Ping Sun; Manuel Alvaro Neto Coelho; Roman Generalov; Natalia Generalova; Ingeborg Lie Christensen
Journal:  Adv Drug Deliv Rev       Date:  2008-09-20       Impact factor: 15.470

10.  Porphyrin conjugated SiC/SiOx nanowires for X-ray-excited photodynamic therapy.

Authors:  F Rossi; E Bedogni; F Bigi; T Rimoldi; L Cristofolini; S Pinelli; R Alinovi; M Negri; S C Dhanabalan; G Attolini; F Fabbri; M Goldoni; A Mutti; G Benecchi; C Ghetti; S Iannotta; G Salviati
Journal:  Sci Rep       Date:  2015-01-05       Impact factor: 4.379

View more
  1 in total

1.  Upconversion in photodynamic therapy: plumbing the depths.

Authors:  Michael R Hamblin
Journal:  Dalton Trans       Date:  2018-02-16       Impact factor: 4.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.